1-(4-(pentyloxy)phenyl)biguanide | 4155-65-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-(4-(pentyloxy)phenyl)biguanide
• 英文别名: 1-(Diaminomethylidene)-2-(4-pentoxyphenyl)guanidine
• CAS: 4155-65-1
• 化学式: C₁₃H₂₁N₅O
• 分子量: 263.343
• InChiKey: JJVXERSUKLYMLN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  19
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  112
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  4-戊氧基苯胺 、 二聚氰胺 在 盐酸 作用下， 以 乙腈 为溶剂， 生成 1-(4-(pentyloxy)phenyl)biguanide
  参考文献：
  名称：

  PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IMMUNE DISEASES OR INFLAMMATORY DISEASES, CONTAINING BIGUANIDE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT

  摘要：

  本发明涉及一种大叶腺苷衍生物化合物，能够有效预防和治疗免疫性疾病。根据本发明的大叶腺苷衍生物化合物抑制了炎性细胞因子IL-17和TNF-α的产生，增加了具有免疫调节功能的调节性T细胞的活性，并在动物模型中展现出优秀的治疗效果。因此，这种基于大叶腺苷衍生物的化合物可以用作免疫抑制剂或药物组合物，能够预防或治疗由免疫反应失调引起的各种免疫性疾病，如自身免疫性疾病、炎症性疾病和移植排斥等。

  公开号：

  US20170333370A1

文献信息

• Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient
  申请人：THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY—ACADEMIC COOPERATION FOUNDATION

  公开号：US10369121B2

  公开（公告）日：2019-08-06

  The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-α, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.

  本发明涉及一种能够有效预防和治疗免疫性疾病的双胍类衍生物化合物。根据本发明的双胍基衍生物化合物可抑制炎性细胞因子 IL-17 和 TNF-α的生成，提高具有免疫调节功能的调节性 T 细胞的活性，并在免疫疾病动物模型中表现出良好的治疗效果。因此，该双胍基衍生物化合物可有效用作免疫抑制剂或药物组合物，能够预防或治疗各种免疫疾病，例如由免疫反应失调引起的自身免疫性疾病、炎症性疾病和移植排斥反应。
• [EN] PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IMMUNE DISEASES OR INFLAMMATORY DISEASES, CONTAINING BIGUANIDE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT<br/>[FR] COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER DES MALADIES IMMUNITAIRES OU DES MALADIES INFLAMMATOIRES, CONTENANT UN COMPOSÉ DE DÉRIVÉ DE BIGUANIDE COMME PRINCIPE ACTIF
  申请人：CATHOLIC UNIV KOREA INDUSTRY ACADEMIC COOPERATION FOUNDATION

  公开号：WO2015026215A1

  公开（公告）日：2015-02-26

  본 발명은 면역질환을 효과적으로 예방 및 치료할 수 있는 바이구아나이드(biguanide) 유도체 화합물에 관한 것이다. 본 발명의 바이구아나이드계 유도체 화합물은 염증성 사이토카인인 IL-17 및 TNF-α의 생성을 억제시키며, 면역조절 기능을 갖는 조절 T 세포의 활성을 증대시킬 뿐만 아니라, 면역질환 동물모델에 대해 우수한 치료 효과를 나타낸다. 따라서 각종 면역반응의 조절 이상으로 유발되는 자가면역질환, 염증성질환 및 이식거부질환과 같은 면역질환을 예방 또는 치료할 수 있는 약학적 조성물 또는 면역 억제제로 유용하게 사용될 수 있다.
• [EN] PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IMMUNE DISEASES OR INFLAMMATORY DISEASES, CONTAINING BIGUANIDE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT<br/>[FR] COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER DES MALADIES IMMUNITAIRES OU DES MALADIES INFLAMMATOIRES, CONTENANT UN COMPOSÉ DE DÉRIVÉ DE BIGUANIDE COMME PRINCIPE ACTIF<br/>[KO] 바이구아나이드 유도체 화합물을 유효성분으로 포함하는 면역질환 또는 염증질환의 예방 또는 치료용 약제학적 조성물
  申请人：CATHOLIC UNIV KOREA INDUSTRY ACADEMIC COOPERATION FOUNDATION

  公开号：WO2015026215A9

  公开（公告）日：2015-06-04

  [EN] The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-α, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.
  [FR] La présente invention concerne un composé de dérivé de biguanide pouvant prévenir et traiter efficacement des maladies immunitaires. Le composé de dérivé à base de biguanide selon la présente invention empêche la génération de IL-17 et TNF-α, qui sont des cytokines inflammatoires, augmente l'activité de lymphocytes T régulateurs ayant une fonction immunomodulatrice, et présente d'excellents effets thérapeutiques chez des modèles animaux atteints de maladies immunitaires. Par conséquent, le composé de dérivé à base de biguanide peut être utilisé efficacement comme immunosuppresseur ou comme composition pharmaceutique pouvant prévenir ou traiter diverses maladies immunitaires, telles que des maladies auto-immunes, des maladies inflammatoires et un rejet de greffe, causées par le dérèglement des réponses immunitaires.
  [KO] 본 발명은 면역질환을 효과적으로 예방 및 치료할 수 있는 바이구아나이드(biguanide) 유도체 화합물에 관한 것이다. 본 발명의 바이구아나이드계 유도체 화합물은 염증성 사이토카인인 IL-17 및 TNF-α의 생성을 억제시키며, 면역조절 기능을 갖는 조절 T 세포의 활성을 증대시킬 뿐만 아니라, 면역질환 동물모델에 대해 우수한 치료 효과를 나타낸다. 따라서 각종 면역반응의 조절 이상으로 유발되는 자가면역질환, 염증성질환 및 이식거부질환과 같은 면역질환을 예방 또는 치료할 수 있는 약학적 조성물 또는 면역 억제제로 유용하게 사용될 수 있다.